← Back to Search

Antibiotic

Testing and treatment for Gonorrhea

N/A
Waitlist Available
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this outcome will be assessed at the first postnatal care visit prior to four weeks after delivery.
Awards & highlights

Study Summary

This trial will compare standard care for chlamydia and gonorrhea during pregnancy to testing and treatment for these STDs. The goal is to see if testing and treatment can reduce adverse pregnancy and birth outcomes.

Eligible Conditions
  • Gonorrhea
  • Chlamydia
  • Neonatal Infections
  • Premature Birth

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this outcome will be assessed at the first postnatal care visit prior to four weeks after delivery.
This trial's timeline: 3 weeks for screening, Varies for treatment, and this outcome will be assessed at the first postnatal care visit prior to four weeks after delivery. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neonatal Chlamydia trachomatis or Neisseria gonorrhoeae infection
Secondary outcome measures
Preterm birth

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Testing and treatmentExperimental Treatment1 Intervention
Participants will receive CT and NG testing and treatment (if necessary) at their first antenatal care visit and a visit during their third trimester. Women will also receive support for partner notification. All women will receive postnatal testing and treatment. Those who test positive at the postnatal visit will be offered infant testing.
Group II: Standard of careActive Control1 Intervention
Participants will receive the standard of care for STI management, which is treatment based on signs and symptoms. Women will also receive support for partner notification. All women will receive postnatal testing and treatment. Those who test positive at the postnatal visit will be offered infant testing.

Find a Location

Who is running the clinical trial?

Botswana Harvard AIDS Institute PartnershipOTHER
12 Previous Clinical Trials
25,645 Total Patients Enrolled
University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,595,778 Total Patients Enrolled
2 Trials studying Gonorrhea
3,103 Patients Enrolled for Gonorrhea
University of California, San DiegoOTHER
1,120 Previous Clinical Trials
1,520,907 Total Patients Enrolled
2 Trials studying Gonorrhea
1,828 Patients Enrolled for Gonorrhea

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still accessible for this experiment?

"The clinical trial's records on clinicaltrials.gov display that it is presently not accepting participants, having first been posted on February 24th 2021 and most recently edited on May 4th 2022. However, there are still 1,042 other studies requiring volunteers at this time."

Answered by AI
Recent research and studies
BMC Infectious DiseasesJournal
Evaluating the Diagnosis and Treatment of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Pregnant Women to Prevent Adverse Neonatal Consequences in Gaborone, Botswana: Protocol for the Maduo Study
Wynn, Adriane, Aamirah Mussa, Rebecca Ryan, Emily Hansman, Selebaleng Simon, Bame Bame, Badani Moreri-Ntshabele, Doreen Ramogola-Masire, Jeffrey D. Klausner, and Chelsea Morroni. 2022. “Evaluating the Diagnosis and Treatment of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Pregnant Women to Prevent Adverse Neonatal Consequences in Gaborone, Botswana: Protocol for the Maduo Study”. BMC Infectious Diseases. Springer Science and Business Media LLC. doi:10.1186/s12879-022-07093-z.
clinicaltrials.govStudy
Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences
Jeffrey D Klausner 2021. "Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04955717.
~120 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top